ロード中...
Overcoming Resistance to FLT3 Inhibitors in the Treatment of FLT3-Mutated AML
Acute myeloid leukaemia (AML) carrying internal tandem duplication (ITD) of Fms-Like Tyrosine kinase 3 (FLT3) gene is associated with high risk of relapse and poor clinical outcome upon treatment with conventional chemotherapy. FLT3 inhibitors have been approved for the treatment of this AML subtype...
保存先:
| 出版年: | Int J Mol Sci |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7073218/ https://ncbi.nlm.nih.gov/pubmed/32102366 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21041537 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|